variables: 817017

This table contains all the variables of all the datasets we have at Our World In Data. Note that this includes only the information about the variables like name and default display settings, not the data itself.

Data license: CC-BY

This data as json

id name unit description createdAt updatedAt code coverage timespan datasetId sourceId shortUnit display columnOrder originalMetadata grapherConfigAdmin shortName catalogPath dimensions schemaVersion processingLevel processingLog titlePublic titleVariant attributionShort attribution descriptionShort descriptionFromProducer descriptionKey descriptionProcessing licenses license grapherConfigETL type sort dataChecksum metadataChecksum
817017 Bacteriologically confirmed pulmonary tuberculosis patients with rifampicin resistance and resistance to fluoroquinolones, bedaquiline and linezolid patients   2023-12-05 11:52:02 2024-07-25 22:54:12     2020-2022 6308     
{
    "unit": "patients",
    "numDecimalPlaces": 0
}
 0     rr_fqr_bdqr_lzdr grapher/tuberculosis/2023-11-27/drug_resistance_surveillance/drug_resistance_surveillance#rr_fqr_bdqr_lzdr   2 major           Number of bacteriologically confirmed pulmonary tuberculosis patients with rifampicin resistance and resistance to fluoroquinolones, bedaquiline and linezolid. Rifampicin resistance is the ability of tuberculosis bacteria, to resist the effects of the antibiotic rifampicin due to genetic mutations, hindering the drug's ability to inhibit bacterial growth. Fluoroquinolones, bedaquiline and linezolid are antibiotics used to treat tuberculosis after first-line drugs such as rifampicin are no longer effective. Number of new or previously treated bacteriologically confirmed pulmonary tuberculosis patients with resistance to rifampicin, fluoroquinolones, bedaquiline and linezolid. 
[]
         int 
[]
 780ccb1d683523330e7e5fdec487b12a a68778a0e18b6c24dea9807949d8b3d1

Links from other tables